OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 134 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $36,000 | -51.4% | 83,934 | -35.6% | 0.00% | – |
| Q1 2016 | $74,000 | -49.3% | 130,366 | +54.3% | 0.00% | – |
| Q4 2015 | $146,000 | -76.5% | 84,464 | -71.3% | 0.00% | -100.0% |
| Q3 2015 | $622,000 | +200.5% | 294,683 | +607.0% | 0.00% | – |
| Q2 2015 | $207,000 | -11.9% | 41,683 | +39.2% | 0.00% | – |
| Q1 2015 | $235,000 | -35.1% | 29,942 | -49.9% | 0.00% | – |
| Q4 2014 | $362,000 | -81.3% | 59,742 | -86.9% | 0.00% | -100.0% |
| Q3 2014 | $1,941,000 | -35.7% | 455,632 | -6.8% | 0.00% | -33.3% |
| Q2 2014 | $3,020,000 | -12.2% | 488,748 | -7.6% | 0.00% | -25.0% |
| Q1 2014 | $3,438,000 | +11.6% | 528,936 | -3.4% | 0.00% | +33.3% |
| Q4 2013 | $3,082,000 | -6.9% | 547,414 | +1.5% | 0.00% | 0.0% |
| Q3 2013 | $3,311,000 | -17.7% | 539,232 | -21.6% | 0.00% | -25.0% |
| Q2 2013 | $4,022,000 | – | 687,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |